FSHD REACH

Welcome to the Brand page for “FSHD REACH”, which is offered here for Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals;fshd;clinical research in the field of facioscapulohumeral muscular dystrophy/atrophy; testing, inspection, research, or development of pharmaceutical preparations for treatment of facioscapulohumeral muscular dystrophy/atrophy; pharmaceutical products development; development of pharmaceutical preparations and medicines;.

Its status is currently believed to be active. Its class is unavailable. “FSHD REACH” is believed to be currently owned by “Fulcrum Therapeutics, Inc.”